Target
Cytochrome P450 2C19
Ligand
BDBM26467
Substrate
BDBM26481
Meas. Tech.
P450 Inhibition Assay
pH
7.4±n/a
Temperature
310.15±n/a K
IC50
7200±n/a nM
Citation
 Harris, PABoloor, ACheung, MKumar, RCrosby, RMDavis-Ward, RGEpperly, AHHinkle, KWHunter, RNJohnson, JHKnick, VBLaudeman, CPLuttrell, DKMook, RANolte, RTRudolph, SKSzewczyk, JRTruesdale, ATVeal, JMWang, LStafford, JA Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor. J Med Chem 51:4632-40 (2008) [PubMed]  Article 
Target
Name:
Cytochrome P450 2C19
Synonyms:
CP2CJ_HUMAN | CYP2C19 | CYPIIC17 | CYPIIC19 | Cytochrome P450 2C19 (CYP2C19) | Cytochrome P450 2C19 [I331V] | Mephenytoin 4-hydroxylase | P450-11A | P450-254C
Type:
Enzyme
Mol. Mass.:
55935.47
Organism:
Homo sapiens (Human)
Description:
P33261
Residue:
490
Sequence:
MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDVSKSLTNLSKIYGPVFTLYFGLERMVVLHGYEVVKEALIDLGEEFSGRGHFPLAERANRGFGIVFSNGKRWKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFQKRFDYKDQQFLNLMEKLNENIRIVSTPWIQICNNFPTIIDYFPGTHNKLLKNLAFMESDILEKVKEHQESMDINNPRDFIDCFLIKMEKEKQNQQSEFTIENLVITAADLLGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVVGRNRSPCMQDRGHMPYTDAVVHEVQRYIDLIPTSLPHAVTCDVKFRNYLIPKGTTILTSLTSVLHDNKEFPNPEMFDPRHFLDEGGNFKKSNYFMPFSAGKRICVGEGLARMELFLFLTFILQNFNLKSLIDPKDLDTTPVVNGFASVPPFYQLCFIPV
  
Inhibitor
Name:
BDBM26467
Synonyms:
3-({4-[methyl(3-methyl-1H-indazol-6-yl)amino]pyrimidin-2-yl}amino)benzene-1-sulfonamide | 3-aminobenzene sulfonamide, 12a
Type:
Small organic molecule
Emp. Form.:
C19H19N7O2S
Mol. Mass.:
409.465
SMILES:
CN(c1ccc2c(C)n[nH]c2c1)c1ccnc(Nc2cccc(c2)S(N)(=O)=O)n1
Structure:
Search PDB for entries with ligand similarity:
Substrate
Name:
BDBM26481
Synonyms:
3-butanoyl-7-methoxy-2H-chromen-2-one | 3-butyryl-7- methoxycoumarin
Type:
Small organic molecule
Emp. Form.:
C14H14O4
Mol. Mass.:
246.2586
SMILES:
CCCC(=O)c1cc2ccc(OC)cc2oc1=O
Structure:
Search PDB for entries with ligand similarity: